InFat
Commercial- Indications
- Infant nutrition
Company intelligence / Profile preview
Enzymotec
Migdal HaEmek, Northern District, Israelen.wikipedia.org ↗
- Ownership
- Private
- Employees
- ~124
- Development stage
- Commercial
01
Overview
Enzymotec developed and commercialized lipid-based nutritional ingredients for infant formula, dietary supplements for cognitive health, and branded medical foods targeting ADHD, memory impairment, and hypertriglyceridemia. Its InFat® product was clinically proven to resemble human breast milk fat. The company was acquired by Frutarom in January 2018.
- Therapeutic areas
- PsychiatryEndocrinologyCardiovascularNeurology
- Modalities
- Small molecule (lipid-based ingredients)Protein (some products contain phospholipids/proteins)Nutritional ingredientMedical food
- Industry
- Food & Nutrition
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Advanced Lipids joint venture with AAK for InFat marketing/distribution.
Beyond the preview
Go deeper on Enzymotec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enzymotec.